NEJM Interview: Dr. Peter Neumann on the use of various new value-based frameworks for assessing drugs and drug prices.
Dec 30, 2015
08:22
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr. Peter Neumann is director of the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. P.J. Neumann and J.T. Cohen. Measuring the Value of Prescription Drugs. N Engl J Med 2015;373:2595-7. R.C. Young. Value-Based Cancer Care. N Engl J Med 2015;373:2593-5.
NEJM Interviews